AMADA, En http://orcid.org/0000-0002-1155-1444
Fukuda, Kazumasa
Kumagai, Koshi http://orcid.org/0000-0001-6165-5105
Kawakubo, Hirofumi
Kitagawa, Yuko
Article History
Received: 18 April 2020
Accepted: 1 August 2020
First Online: 7 August 2020
Compliance with ethical standards
:
: En Amada, Kazumasa Fukuda, Koshi Kumagai and Hirofumi Kawakubo declared no potential conflicts of interest with respect to the research, authorship, or publication of this article. Yuko Kitagawa has received compound of recombinant thrombomodulin (rTM) from Asahi Kasei Pharma, Tokyo, Japan.
: All animal procedures were conducted in accordance with Institutional Guidelines on Animal Experimentation of Keio University and were approved by the ethics committee (approval number: 18077-(0)). All staff that participated in the study received special training in animal care and handling from the Laboratory Animal Center of Keio University of Medicine.